Our Current Research

 

For more than 30 years, magnetic resonance imaging (MRI) research at BIDMC has made major contributions to the advancement of MRI technology and its application to disease characterization and the diagnosis and monitoring of treatment response. Some areas of current research focus are listed below. Please contact us if you are interested in these or other areas of MRI research. 

 

Arterial Spin Labeling Perfusion MRI 

Improving and exploring the capabilities of Arterial Spin Labeling (ASL) is a major focus in the Division. ASL exploits the spatial selectivity of MRI to change the sign of the nuclear spins (responsible for the MRI signal) of the water in inflowing arterial blood. This “labeling” of arterial spins is achieved only with magnetic fields; no injection or radiation is required. Images acquired after allowing for the labeled blood to enter tissue reflect perfusion (the blood flow through the capillaries of tissue). Quantitative images of perfusion can readily be generated using this technique. Since perfusion reflects the activity of tissue along with the health of its blood supply, ASL perfusion MRI has found wide use in studies of the brain, kidneys, and cancer. ASL can also be used to produce high-quality images of the arteries, otherwise known as angiography. The unique noninvasive capabilities of ASL to selectively label individual arteries and create high temporal resolution images of arterial inflow are just now being appreciated. 

Dr. Alsop has been a pioneer of techniques and applications of ASL for clinical research and clinical use. His group has developed improved methods for labeling and evaluated its sensitivity in applications from newborns to Alzheimer’s Disease, and stroke to cancer. Partnering with MRI vendors, his group has influenced the commercialization of ASL for more widespread use. With funding from the National Institutes of Health and GE Healthcare, his group is currently working to improve the reliability and precision of ASL in the brain and expand its use to applications in the body. Some recent areas of focus include 

  1. Improving the reproducibility of brain ASL perfusion across time and subjects to enhance the sensitivity of research and clinical use. 

  1. Quantifying correlated fluctuations of brain networks using ASL and understanding the relationship between network fluctuations and time-averaged network perfusion. 

  1. Characterizing alterations in the blood-brain barrier with aging using ASL. 

  1. Measuring the effects of antiangiogenic therapy on perfusion and vascular supply in glioma and renal cancer and their relationship to treatment response. 

  1. Studying blood flow to the eye in the elderly and its relationship to age-related macular degeneration. 

  1. Developing improved methods to display and analyze blood flow images by incorporating information from other images with greater anatomical resolution. 

  1. Developing clinically robust 3-dimensional imaging methods for blood flow imaging of the kidneys and other abdominal organs. 

  1. Characterizing perfusion changes induced by transcranial direct current stimulation. 

Myelin Imaging and Inhomogeneous Magnetization Transfer (ihMT) 

  • David Alsop, PhD, Principal Investigator 
  • Gopal Varma, PhD, Principal Investigator 
  • Fanny Munsch, PhD, Postdoctoral Fellow 

Our lab is currently actively pursuing a new technology for quantitative imaging of myelin, in-vivo. Myelin is a sheath, located around nerves, which is essential to the rapid communication of neural signals. Myelination occurs rapidly during infant development as the child experiences new stimuli. Even in adults, myelination has been shown to contribute to long-term skill acquisition and possibly other long-term memory processes. Loss of myelin during aging is a major contributor to cognitive slowing with age. Several disorders also specifically affect myelin including Multiple Sclerosis, Progressive Multifocal Leukoencephalopathy, and even traumatic brain injury. 

Quantitative imaging of myelin would be a valuable tool for the study of brain development, aging, and many disorders. Several techniques for imaging myelin, including magnetization transfer (MT) imaging, separation of T2 relaxation components, and Diffusion Tensor Imaging (DTI) have been explored in the literature. Often these are affected by other factors which, in turn, limit their specificity to myelin. 

Our work builds upon the concept of magnetization transfer (MT) imaging. MT is a technique to make MRI more sensitive to the large, slow-moving macromolecules in tissue. Because these molecules move so slowly, their signal decays too rapidly for imaging with standard MRI techniques, which typically focus on the signal from water. Attenuated signal, or magnetization, from the macromolecules, can exchange with the water signal, however, and thus become visible on water imaging. Saturation of the macromolecule signal can be achieved by applying radiofrequency magnetic fields away from the water frequency. The MT attenuation of the water proton signal in MRI produced by off-resonance radiofrequency irradiation has shown some relationship to the degree of myelination or damage to myelin. Unfortunately, many other molecules contribute to the MT signal such that the specificity to myelin is limited. 

We have developed and reported a refinement of the MT method that makes the signal much more specific to myelin. By subtracting MT images produced by saturating simultaneously at identical positive and negative frequency offsets from the water frequency to those produced by applying all the power at either the positive or negative frequency, we produce an MT image that is selective for macromolecules that have restricted motion but still enough mobility to weaken the interactions between neighboring atoms. This weak interaction can be quantified in terms of the relaxation time for dipolar order, or T1d. T1d is much longer in myelinated tissues than in any other tissue. Because molecules with long T1d are said to be inhomogeneously broadened, we refer to this technique as inhomogeneous Magnetization Transfer or ihMT. 

We continue to work on improving and characterizing the ihMT method. We have demonstrated strong specificity for myelinated tissues in the brain and spine, developed methods to quantify T1d and other ihMT-relevant parameters, and are exploring medical research and clinical applications. Validation against histological measures is still required to prove the myelin specificity of ihMT. This work is currently supported through internal funds and by GE Healthcare, but we are actively seeking additional funding to accelerate the development and characterization of this promising imaging method. 

We are now in the process of optimizing the method and performing some of the first studies with our myelin imaging technique in patient populations. Validation studies in model systems are also being explored. Specific topics include: 

  1. Increasing the myelin signal by brief concentrated applications of radiofrequency power. 

  1. Implementing motion-insensitive methods to increase the robustness of the myelin signal. 

  1. Comparing our myelin methods with other proposed myelin imaging methods, including myelin water imaging. 

  1. Demonstrating the sensitivity of myelin imaging in animal models of multiple sclerosis and potentially other pathologies. 

The IHMTR shows greater contrast from WM than the MTR above T1 weighted anatomic images from a volunteer, top, and corresponding ihMT myelin maps, bottom. 

Related Publications 

  1. Ercan E, Varma G, Dimitrov IE, Xi Y, Pinho MC, Yu FF, Zhang S, Wang X, Madhuranthakam AJ, Lenkinski RE, Alsop DC, Vinogradov E. Combining inhomogeneous magnetization transfer and multipoint Dixon acquisition: Potential utility and evaluation. Magn Reson Med. 2021 Apr;85(4):2136-2144. doi: 10.1002/mrm.28571. Epub 2020 Oct 26. PMID: 33107146  
  2. Munsch F, Varma G, Taso M, Girard O, Guidon A, Duhamel G, Alsop DC. Characterization of the cortical myeloarchitecture with inhomogeneous magnetization transfer imaging (ihMT). Neuroimage. 2021 Jan 15;225:117442. doi: 10.1016/j.neuroimage.2020.117442. Epub 2020 Oct 9. PMID: 33039620  
  3. Varma G, Munsch F, Burns B, Duhamel G, Girard OM, Guidon A, Lebel RM, Alsop DC.Three-dimensional inhomogeneous magnetization transfer with rapid gradient-echo (3D ihMTRAGE) imaging. Magn Reson Med. 2020 Dec;84(6):2964-2980. doi: 10.1002/mrm.28324. Epub 2020 Jun 30. PMID: 32602958  
  4. Varma G, Girard OM, Mchinda S, Prevost VH, Grant AK, Duhamel G, Alsop DC. Low-duty-cycle pulsed irradiation reduces magnetization transfer and increases the inhomogeneous magnetization transfer effect. J Magn Reson. 2018 Nov;296:60-71. doi: 10.1016/j.jmr.2018.08.004. Epub 2018 Aug 31. PMID: 30212729  
  5. Ercan E, Varma G, Mädler B, Dimitrov IE, Pinho MC, Xi Y, Wagner BC, Davenport EM, Maldjian JA, Alsop DC, Lenkinski RE, Vinogradov E. Microstructural correlates of 3D steady-state inhomogeneous magnetization transfer (ihMT) in the human brain white matter assessed by myelin water imaging and diffusion tensor imaging. Magn Reson Med. 2018 Apr 29. doi: 10.1002/mrm.27211. [Epub ahead of print] PMID: 29707813 
  6. Van Obberghen E, Mchinda S, le Troter A, Prevost VH, Viout P, Guye M, Varma G, Alsop DC, Ranjeva JP, Pelletier J, Girard O, Duhamel G. Evaluation of the Sensitivity of Inhomogeneous Magnetization Transfer (ihMT) MRI for Multiple Sclerosis. AJNR Am J Neuroradiol. 2018 Feb 22. doi: 10.3174/ajnr.A5563. [Epub ahead of print] PMID: 29472299 
  7. Mchinda S, Varma G, Prevost VH, Le Troter A, Rapacchi S, Guye M, Pelletier J, Ranjeva JP, Alsop DC, Duhamel G, Girard OM. Whole brain inhomogeneous magnetization transfer (ihMT) imaging: Sensitivity enhancement within a steady-state gradient echo sequence. Magn Reson Med. 2017 Sep 23. doi: 10.1002/mrm.26907. PMID: 28940355 
  8. Geeraert BL, Lebel RM, Mah AC, Deoni SC, Alsop DC, Varma G, Lebel C. A comparison of inhomogeneous magnetization transfer, myelin volume fraction, and diffusion tensor imaging measures in healthy children. Neuroimage. 2018 Nov 15;182:343-350. doi: 10.1016/j.neuroimage.2017.09.019. Epub 2017 Sep 12. PMID: 28916179 
  9. Prevost VH, Girard OM, Mchinda S, Varma G, Alsop DC, Duhamel G. Optimization of inhomogeneous magnetization transfer (ihMT) MRI contrast for preclinical studies using dipolar relaxation time (T1D ) filtering. NMR Biomed. 2017 Jun;30(6). doi: 10.1002/nbm.3706. Epub 2017 Feb 14. PMID: 28195663 
  10. Varma G, Girard OM, Prevost VH, Grant AK, Duhamel G, Alsop DC. In vivo measurement of a new source of contrast, the dipolar relaxation time, T1D, using a modified inhomogeneous magnetization transfer (ihMT) sequence. Magn Reson Med. 2017 Oct;78(4):1362-1372. doi: 10.1002/mrm.26523. Epub 2016 Nov 17. PMID: 27859618 
  11. Girard OM, Callot V, Prevost VH, Robert B, Taso M, Ribeiro G, Varma G, Rangwala N, Alsop DC, Duhamel G. Magnetization transfer from inhomogeneously broadened lines (ihMT): Improved imaging strategy for spinal cord applications. Magn Reson Med. 2017 Feb;77(2):581-591. doi: 10.1002/mrm.26134. Epub 2016 Mar 9. PMID: 26959278 
  12. Prevost VH, Girard OM, Varma G, Alsop DC, Duhamel G. Minimizing the effects of magnetization transfer asymmetry on inhomogeneous magnetization transfer (ihMT) at ultra-high magnetic field (11.75 T). MAGMA. 2016 Aug;29(4):699-709. doi: 10.1007/s10334-015-0523-2. Epub 2016 Jan 13. PMID: 26762244 
  13. Varma G, Girard OM, Prevost VH, Grant AK, Duhamel G, Alsop DC. Interpretation of magnetization transfer from inhomogeneously broadened lines (ihMT) in tissues as a dipolar order effect within motion-restricted molecules. J Magn Reson. 2015 Nov;260:67-76. doi: 10.1016/j.jmr.2015.08.024. Epub 2015 Sep 7. PMID: 26408956 
  14. Varma G, Duhamel G, de Bazelaire C, Alsop DC. Magnetization transfer from inhomogeneously broadened lines: A potential marker for myelin. Magn Reson Med. 2015 Feb;73(2):614-22. doi: 10.1002/mrm.25174. Epub 2014 Mar 6. PMID: 24604578 

Hyperpolarization 

Aaron K Grant, PhD, Principal Investigator  

In conventional MRI, the strong magnetic field of the scanner is used to align the magnetization of individual nuclei. However, the magnetic field interaction is weak compared to thermal energy so the net alignment is only a few millionths. Because of this low alignment, only very highly concentrated molecules, especially water in the body, can be imaged with MRI. 

An alternative to thermal polarization is to use special techniques outside the body to hyperpolarize the nuclei so that nearly all of them are along the magnetic field. This increases the signal by a factor of 10000 or more. When injected in the body, these nuclei can be observed as molecular tracers. In particular, molecules labeled with stable carbon-13 can be used to probe membrane transport, enzyme activity, and metabolism in-vivo. BIDMC is fortunate to have one of the few Dynamic Nuclear Polarization (DNP) systems and has been pursuing research on hyperpolarization for years. 

The BIDMC team, led by Dr. Aaron Grant, has been developing new technologies and applying them to the study of metabolic therapies in cancer. Technical developments include new balanced SSFP acquisition methods for high spatial and temporal resolution imaging while separating the different metabolic products of hyperpolarized tracers, and the development of new tracers such as hyperpolarized t-butanol that can be used as an excellent perfusion tracer. Dr. Grant has a particular focus on metabolism in cancer, including the study of glycolysis and its inhibition along with alternative fuels for cancer metabolism when glucose metabolism is blocked by enzyme target drugs. 

Related Publications  

  1. Varma G, Seth P, Coutinho de Souza P, Callahan C, Pinto J, Vaidya M, Sonzogni O, Sukhatme V, Wulf GM, Grant AK. Visualizing the effects of lactate dehydrogenase (LDH) inhibition and LDH-A genetic ablation in breast and lung cancer with hyperpolarized pyruvate NMR. NMR Biomed. 2021 Aug;34(8):e4560. doi: 10.1002/nbm.4560. Epub 2021 Jun 4. PMID: 34086382  
  2. Goodwin JS, Tsai LL, Mwin D, Coutinho de Souza P, Dialani S, Moon JT, Zhang Z, Grant AK, Ahmed M. In vivo detection of distal tumor glycolytic flux stimulated by hepatic ablation in a breast cancer model using hyperpolarized 13C MRI. Magn Reson Imaging. 2021 Jul;80:90-97. doi: 10.1016/j.mri.2021.04.004. Epub 2021 Apr 24. PMID: 33901585  
  3. Selective spectroscopic imaging of hyperpolarized pyruvate and its metabolites using a single-echo variable phase advance method in balanced SSFP. Varma G, Wang X, Vinogradov E, Bhatt RS, Sukhatme VP, Seth P, Lenkinski RE, Alsop DC, Grant AK. Magn Reson Med. 2016 Oct;76(4):1102-15. doi: 10.1002/mrm.26004. Epub 2015 Oct 28. PMID: 26507361  
  4. Grant AK, Vinogradov E, Wang X, Lenkinski RE, Alsop DC. Perfusion imaging with a freely diffusible hyperpolarized contrast agent. Magn Reson Med. 2011 Sep;66(3):746-55. doi: 10.1002/mrm.22860. Epub 2011 Mar 22. PMID: 21432901  

Return to the MRI Research landing page.